Hemant Surgical Industries Limited has submitted its quarterly compliance certificate to BSE Limited, confirming that the company's entire shareholding remains in dematerialised form for the quarter ended March 31, 2026.

Regulatory Compliance Certificate

The company filed its certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 on April 7, 2026. The submission confirms that the regulation is not applicable to the company due to specific compliance conditions being met.

Share Holding Status

The certificate confirms two key compliance aspects for the quarter:

• The entire holding of the company's shares remains in demat form
• No requests for rematerialisation were received from any members during the quarter

These conditions render Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 not applicable to the company for this reporting period.

Registrar Confirmation

Bigshare Services Pvt. Ltd., serving as the company's registrar and share transfer agent, issued the compliance certificate on April 6, 2026. The certificate was signed by Akash Shamal, Authorised Signatory of Bigshare Services.

Management Submission

The filing was submitted to BSE Limited by Hanskumar Shamji Shah, Managing Director of Hemant Surgical Industries Limited. The digital submission was completed on April 7, 2026, ensuring timely regulatory compliance.

This compliance filing demonstrates the company's adherence to SEBI regulations regarding dematerialised shareholding and maintains transparency with regulatory authorities and stakeholders.

Hemant Surgical Industries Limited has entered into a strategic C-ARM Development and Supply Agreement with GBT Korea Co., Ltd., Republic of Korea, as announced through a regulatory filing under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The agreement was disclosed on April 02, 2026, and signed by Managing Director Hanskumar Shamji Shah.

Partnership Objectives and Technology Focus

The collaboration is designed to leverage GBT Korea's strong technological expertise in developing and localizing advanced medical imaging equipment. The partnership will focus on three key technological areas:

• X-ray generators development and localization
• Electronic control systems for medical imaging
• C-arm imaging devices utilizing fluoroscopy x-ray technology

These imaging systems are specifically designed to provide real-time high-resolution imaging during critical surgical procedures, including orthopedic, trauma, and cardiovascular operations.

Agreement Structure and Terms

Regulatory Compliance and Disclosures

The company has confirmed that this agreement does not fall within related party transactions framework. Key regulatory aspects include:

• No shareholding arrangements between the parties
• No special rights provisions such as director appointment rights
• No share subscription or capital structure restrictions
• Arms-length transaction structure maintained

The agreement does not involve any share issuance, loan arrangements, or other financial instruments. Both parties have agreed to maintain confidentiality regarding the financial size of the agreement.

Strategic Implications

This partnership represents Hemant Surgical Industries' strategic move to enhance its technological capabilities in the medical imaging sector. The collaboration with GBT Korea aims to bring advanced fluoroscopy technology to the Indian market, potentially strengthening the company's position in surgical equipment manufacturing.

The agreement focuses on developing imaging solutions that provide real-time visualization capabilities, which are crucial for precision in modern surgical procedures across orthopedic, trauma, and cardiovascular specialties.